Analysis of Recurrent Stroke Volume and Prognosis between Warfarin and Four Non–Vitamin K Antagonist Oral Anticoagulants’ Administration for Secondary Prevention of Stroke

0

We investigated recurrent stroke volume with nonvalvular atrial fibrillation (NVAF) patients treated with non–vitamin K antagonist oral anticoagulants (NOACs) about clinical backgrounds and number of recurrent stroke.

Read More...

Leave A Reply